Mostly diagnosis is very difficult in the ED and should be a diagnosis of exclusion. The prevalence of Munchausen syndrome is rare but most patients presenting with the disorder are admitted to hospital through the ED because of the dramatic presentation of an apparently severe illnesses [5]. The potential for significant inadvertent morbidity and mortality exists;

in our patient the needle could have caused a perforation of the aorta or other organs. Further diagnostic procedures and treatment interventions can also cause more morbidity or mortallity, by the intervention BKM120 research buy itself or through the

patients contribution (eg. taking anticoagulant drugs). In contrast to this case most of the Munchausen syndrome present in males and incidence peaks in young-to-middle-aged adults, mostly moving to different physicians and hospitals repeatedly simulating or self-inducing a single medical problem or with a wide diversity of medical problems leading to a lack of medical documentation to substantiate the self-reported medical history [6]. Physical examination can be very contributive in checking patients history but not in diagnosis because the great LEE011 mimicking capacity of the subject to generate physical findings and symptoms. Although our patient asked for a psychiatric interview most patients Glutamate dehydrogenase are seldom willing to admit that they have feigned or caused their own medical problems. After treatment

of the selfinduced disease, patients mostly discharge against medical advice because they are afraid that truth will come above, or start lying resulting in chronic lying behaviour. Differential diagnosis with other psychiatric disorders must be made. Conversion disorders, hypochondriasis, malingering, somatisation disorders and Munchausen by proxi are to be considered. The patient suffering Munchausen syndrome or Munchausen by proxy (mostly children) have no clear gain and Munchausen patients actively seek hospitalization and invasive painful procedures simply to undergo them, whereas in self-mutilation the injury is intended to assist the individual in dissociating from immediate tension. Cause and pathophysiology remain unclear and the prevalence of factitious disorders is probably in the range of 0.2-1% of hospital inpatients.

Pneumonia, of which the pneumococcus is the leading cause, still accounts worldwide for over 150 million clinical episodes yearly, which contribute to approximately 1.9 million deaths [1]. Even more frequent are non-invasive pneumococcal acute conjunctivitis and otitis media. Pneumococci are also part of the normal flora of humans, as they colonise the nasopharynx soon after birth and carriage selleckchem is reported

to be self limited to periods from few days to few months [2, 3]. Successive carriage episodes are generally due to strains of different capsular types. Progression to invasive disease occurs within the first weeks of carriage [2]. Recently, interest has been raised on physiology of bacteria in different niches of their natural environment: the human host. Direct microscopy analysis, carried out on human biopsy specimens of the sinus and the middle ear mucosa and the adenoids showed the presence of pneumococcal cells embedded in extracellular matrix indicative of microbial biofilms [4–6]. Recently, the presence of biofilm-like structures in the lungs of animals infected with S. pneumoniae was also documented [7]. These studies provided important evidence that pneumococci in different diseases are not behaving as planktonic cells, but predominantly show characteristics of a biofilm like state. Pneumococcal

animal models of disease as well as models of carriage have been associated to biofilm-like infections selleck compound [8–13]. It has been shown that gene expression of pneumococci during infection of lungs and meninges in mice was comparable to that of pneumococcal biofilms [8]. In this model the development of biofilm depended on the competence system, and the addition of the competence stimulating peptide SSR128129E (CSP) to the medium was necessary for biofilm formation. The direct association of the competence system to pneumococcal disease was demonstrated by the fact that virulence in sepsis and pneumonia could be modulated by CSP and by showing increase of disease severity in mice directly challenged with biofilm

cells [8, 14]. The correlation of biofilm to carriage was confirmed by mutants that produced less biofilm in an in vitro model and also showed reduction in their colonisation capacity [9]. Recent data from our group showed that free sialic acid in culture medium represents the signal necessary for biofilm formation. Furthermore, this signal increases pneumococcal colonisation and translocation to the lung in mouse models of carriage [10]. It is of interest to underline that despite existence of pneumococcal biofilms in humans and correlation between virulence in experimental infection models and aspects of biofilm, so far no important correlation of pneumococcal clinical isolates, clones, serotypes, or MLST types to their capacity to form in vitro a biofilm was shown [15, 16]. Biofilm models are less standardised than the classical mid log growth phase, in which most microbiological research has been done.

Infect Immun 2006, 74:3845–3852.PubMedCrossRef 34. Braz VS, Marques MV: Genes involved in cadmium resistance in Caulobacter crescentus . FEMS Microbiol Lett 2005, 251:289–295.PubMedCrossRef 35. Hu P, Brodie EL, Suzuki Y, McAdams HH,

Andersen GL: Whole-genome transcriptional analysis of heavy metal stresses in Caulobacter crescentus . J Bacteriol 2005, 187:8437–8449.PubMedCrossRef 36. Grosse C, Anton A, Hoffmann T, Franke S, Schleuder G, Nies DH: Identification of a regulatory pathway that controls the heavy-metal resistance system Czc via promoter czcNp in Ralstonia metallidurans . Arch Microbiol 2004, 182:109–118.PubMedCrossRef 37. McGrath PT, Lee MEK162 concentration H, Zhang VS-4718 in vitro L, Iniesta AA, Hottes AK, Tan MH, Hillson NJ, Hu P, Shapiro L, McAdams HH: High-throughput identification of transcription start sites, conserved promoter motifs and predicted regulons. Nat Biotechnol 2007, 25:584–592.PubMedCrossRef 38. Miller JH: Experiments in Molecular Genetics. New York: Cold Spring Harbor,

Laboratory Press; 1972. [1] 39. Nierman WC, Feldblyum TV, Laub MT, Paulsen IT, Nelson KE, Eisen JA, Heidelberg JF, Alley MR, Ohta N, Maddock JR: Complete genome sequence of Caulobacter crescentus . Proc Natl Acad Sci USA 2001, 98:4136–4141.PubMedCrossRef 40. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, et al.: Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947–2948.PubMedCrossRef 41. Liesegang H, Lemke K, Siddiqui RA, Schlegel HG: Characterization of the inducible nickel and cobalt resistance determinant cnr from pMOL28 of Alcaligenes eutrophus CH34. J Bacteriol 1993, 175:767–778.PubMed 42. Crooks GE, Hon G, Chandonia JM, Brenner SE: WebLogo: A sequence logo generator. Genome Res 2004, 14:1188–1190.PubMedCrossRef 43. The PyMOL Molecular Graphics System. Version 1.5.0.4 Schrödinger, LLC. 44. Kelley LA, Sternberg MJE: Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 2009, 4:363–371.PubMedCrossRef

45. Su CC, Long F, Zimmermann MT, Rajashankar ID-8 KR, Jernigan RL, Yu EW: Crystal structure of the CusBA heavy-metal efflux complex of Escherichia coli . Nature 2011, 470:558–562.PubMedCrossRef 46. Ely B: Genetics of Caulobacter crescentus . Methods Enzymol 1991, 204:372–384.PubMedCrossRef 47. Hanahan D: Studies on transformation of Escherichia coli with plasmids. J Mol Biol 1983, 166:557–580.PubMedCrossRef 48. Simon R, Prieffer U, Puhler A: A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram-negative bacteria. Nat Biotechnol 1983, 1:784–791.CrossRef 49. Evinger M, Agabian N: Envelope-associated nucleoid from Caulobacter crescentus stalked and swarmer cells. J Bacteriol 1977, 132:294–301.PubMed 50.

2008; Buscardo et al. 2008) vary greatly depending

upon the characteristics of both the plantations and of the previous land uses. Synthesizing individual case studies and evaluating the patterns that emerge across cases can help to explain this diversity of outcomes observed with plantation establishment. In a global review of biodiversity of multiple taxa in plantations compared to pasture lands, Felton et al. (2010) found significantly higher amphibian and reptile richness in plantations, but found no significant differences AZD3965 clinical trial in species richness of other taxa, including plants, mammals, and invertebrates in plantations versus pasture lands. Pointing to “unexplained heterogeneity between studies,” Felton et al. (2010, p. 545) caution against “general statements about the inherent biodiversity value of diverse and broadly-defined land uses.” This conclusion emphasizes the importance of scrutinizing

SC75741 mouse differences within the broad categories of plantations and pasture lands, including whether plantations use exotic or native species, proximity to native vegetation, and prior land-use history. While, in addition to Felton et al.’s (2010) synthesis, several other studies summarize biodiversity and plantation case studies (Carnus et al. 2006; Stephens and Wagner 2007; Brockerhoff et al. 2008), there has yet to be a synthesis of quantitative changes in biodiversity

with plantation establishment across a range of paired land covers and plantation types. Accordingly, this paper synthesizes existing quantitative data available on plant richness in plantations (including those using native for and exotic species) in comparison with alternative land covers (categorized as primary forest, secondary forest, shrubland, grassland, and degraded or exotic pasture) in order to inform land-use policy and stimulate further research. The focus is on between species diversity using plant species richness (including total, exotic, and native species richness) as a proxy for biodiversity. While this will not necessarily reflect biodiversity of other taxa, understory vegetation is considered to be a good predictor of faunal diversity (Humphrey et al. 1999). Moreover, plants are the basis of the food chain and contribute to important ecosystem services including climate regulation, water purification, and pollination (Daily 1997; Goldman et al. 2008). As such, an evaluation of plantations and plant diversity provides valuable information on the effects on vegetation with implications for wider ecosystem services and the faunal diversity they support.

Currently, Hadrospora GDC-0994 order includes two species, i.e. H. fallax and H. clarkii (Sivan.) Boise differentiated by ascospore size. Phylogenetic study None. Concluding remarks Hadrospora seems not closely related to Phaeosphaeriaceae. Halotthia Kohlm., Nova Hedwigia 6: 9 (1963). (?Zopfiaceae) Generic description Habitat marine, saprobic. Ascomata large, solitary, gregarious or confluent, broadly conical to subglobose, flattened at the base, carbonaceous, immersed to erumpent, ostiolate, epapillate. Peridium plectenchymatous. Hamathecium of dense, long, cellular pseudoparaphyses, septate, branching.

Asci 8-spored, bitunicate, cylindrical, with a short pedicel. Ascospores uniseriate, ellipsoidal, subcylindrical or obtuse-fusoid, dark brown, 1-septate, constricted at the septum. Anamorphs reported for genus: none. Literature: Kohlmeyer 1963; Suetrong et al. 2009. Type species Halotthia posidoniae (Durieu & Mont.) Kohlm., Nova Hedwigia 6: 9 (1963). (Fig. 34) Fig. 34 Halotthia posidoniae (from S, isotype of Sphaeria posidoniae). a Ascomata gregarious on the host surface. Adriamycin mouse b–d Mature or

immature cylindrical asci. e–h Ellipsoidal, dark-brown, 1-septate ascospores. Scale bars: a = 1 mm, b–d = 50 μm, e–h = 5 μm ≡ Sphaeria posidoniae Durieu & Mont. Exploration scientifique de l’Algérie, pp. 502–503, Taf. 25, Abb. 8a-i, 1849. Ascomata 0.8–1.1 mm high × 1.5–2.1 mm diam., solitary, gregarious or confluent, broadly conical to subglobose, flattened at the base, carbonaceous, immersed to erumpent, ostiolate, epapillate (Fig. 34a). Peridium ADAM7 165–275 μm thick at sides, thicker near the apex, plectenchymatous. Hamathecium of dense, long cellular pseudoparaphyses, 1.5–2 μm broad, septate, branching. Asci 275–290 × 25–35 μm, 8-spored, bitunicate, cylindrical, with a short pedicel (Fig. 34b, c and d). Ascospores 37–60.5 × 16.5–26 μm, uniseriate, ellipsoidal, subcylindrical or obtuse-fusoid, dark brown, 1-septate, constricted at the septum (Fig. 34e, f, g and h) (adapted from Kohlmeyer and Kohlmeyer 1979). Anamorph: none reported. Material examined: ITALY, in rhizomes

of Posidonia oceanica (Posidoniaceae), 1861, Caldesi (S, isotype of Sphaeria posidoniae) Notes Morphology Halotthia was introduced to accommodate the marine fungus, H. posidoniae (as Sphaeria posidoniae), which is characterized by immersed to erumpent, large, carbonaceous ascomata, thick peridium, bitunicate, 8-spored, cylindrical asci, ellipsoidal, 1-septate, and dark brown ascospores (Kohlmeyer 1963). Morphologically, Halotthia is most comparable with Bicrouania maritima, but the conical ascomata with flattened base of H. posidoniae can be readily distinguished from B. maritima. Phylogenetic study Phylogenetically, Halotthia posidoniae, Pontoporeia biturbinata and Mauritiana rhizophorae form a robust clade, which may represent a potential family (Suetrong et al. 2009).

Acknowledgements The authors wish to thank Prof. Hiroshi Nikaido (Department of Molecular and Cell Biology, University of California, Berkeley, California, U.S.A) and Prof. Michael Niederweis for kindly providing the M. smegmatis mutant strains used in this work and to Prof. Winfried V. Kern (Center for Infectious Diseases and Travel Medicine, University Hospital, Freiburg, Germany) for valuable suggestions and scientific discussions. This work was supported by grants EU-FSE/FEDER-PTDC/BIA-MIC/71280/2006, EU-FSE/FEDER-PTDC/BIA-MIC/105509/2008 and EU-FSE/FEDER-PTDC/SAU-FCF/102807/2008 provided by Fundação para a Ciência e a Tecnologia (FCT) of Portugal. L. Rodrigues was supported

by grant SFRH/BD/24931/2005 (FCT, Portugal). References 1. Brennan PJ, Nikaido H: The envelope of mycobacteria. Annu Rev Biochem 1995, 64: 29–63.PubMedCrossRef 2. Brennan PJ: Structure, function, and learn more biogenesis of the cell wall of Mycobacterium tuberculosis . Tuberculosis 2003, 83: 91–97.PubMedCrossRef 3. Niederweis M: Mycobacterial porins – new channel click here proteins in unique outer membranes. Mol Microbiol 2003, 49: 1167–1177.PubMedCrossRef 4. Niederweis M, Ehrt S, Heinz C, Klöcker

U, Karosi S, Swiderek KM, Riley LW, Benz R: Cloning of the mspA gene encoding a porin from Mycobacterium smegmatis . Mol Microbiol 1999, 33: 933–945.PubMedCrossRef 5. Stahl C, Kubetzko S, Kaps I, Seeber S, Engelhardt H, Niederweis M: MspA provides

the main hydrophilic pathway through the cell wall of Mycobacterium smegmatis . Mol Microbiol 2001, 40: 451–464.PubMedCrossRef 6. Nikaido H: Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin Cell Dev Biol 2001, 12: 215–23.PubMedCrossRef 7. World Health Organization: Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva, Switzerland; 2010. 8. Aínsa JA, Blokpoel MC, Otal I, Young DB, De Smet KA, Martín C: Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium Dapagliflozin tuberculosis . J Bacteriol 1998, 180: 5836–5843.PubMed 9. Choudhuri BS, Bhakta S, Barik R, Basu J, Kundu M, Chakrabarti P: Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis . Biochem J 2002, 367: 279–285.PubMedCrossRef 10. De Rossi E, Aínsa JA, Riccardi G: Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol Rev 2006, 30: 36–52.PubMedCrossRef 11. Siddiqi N, Das R, Pathak N, Banerjee S, Ahmed N, Katoch VM, Hasnain SE: Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap -like efflux pump. Infection 2004, 32: 109–111.PubMedCrossRef 12.

Since Pneumocystis infection results in lung damage, cellular components released may also cause differential gene expression. Among the top 10 up-regulated genes during PCP, the chemokine (C-X-C motif) ligand 10 (Cxcl10) gene was the most highly up-regulated one with a 12-fold increase in expression. CXCL10 binds to the chemokine receptor CXCR3 [50] and chemoattracts monocytes, macrophages, T cells, EPZ015938 cost NK cells, and dendritic cells. It also promotes adhesion of T cells to endothelial cells [51, 52]. The high degree of CXCL10 up-regulation suggests the attempts of the host to enhance AM phagocytosis. The other top up-regulated genes include Spp1, S100A9, Rsad2, S100A8, Nos2,

RT1-Bb, Lcn2, RT1-Db1, and Srgn. These genes encode the secreted phosphoprotein 1 (SPP1), calgranulin A and B complex (S100A8/S100A9), radical S-adenosyl methionine domain containing 2 (RSAD2),

inducible nitric oxide synthase (NOS2), class II MHC Bβ, lipocalin-2 (LCN2), class II MHC Dβ, and serglycin (SRGN) proteins, respectively. As described above, the SPP1 protein plays a role in the activation of both innate and adaptive immunity. The calgranulin A and B complex (S100A8/S100A9) see more have been shown to be a damage-associated pattern molecule which mediates inflammatory responses and recruits inflammatory cells to sites of tissue damage [53]. It can also modulate polymerization of microtubules during migration of phagocytes and induces inflammatory responses in leucocytes and endothelial cells [54, 55]. Their up-regulation in expression during PCP also shows the importance of phagocytosis in the defense against Pneumocystis infection. The RSAD2 protein is also known as viperin. It is an endoplasmic reticulum-associated, interferon-inducible virus inhibitory protein and has been shown to be required for optimal Th2 responses and T-cell receptor-mediated activation of NF-κB and AP-1 [56]. The NOS2 (iNOS) protein is responsible for the production of nitric oxide which is an antimicrobial compound [57]. The lipocalin-2

protein (LCN2) is a component of granules in neutrophils from tissues that are normally exposed to microorganisms. Its level is increased during inflammation [58]. LCN2 exerts bacteriostatic effects by its ability to capture and deplete siderophores that are small iron-binding molecules synthesized Immune system by certain bacteria as a means of iron acquisition [58]. Although Pneumocystis siderophores have not been identified and the role of LCN2 in PCP is unknown, iron is known to be essential for the proliferation of Pneumocystis [59], and deferoxamine, which is an iron chelator, has been used to treat PCP in animal models [59]. Serglycin (SRGN) is a proteoglycan mainly produced by hematopoietic and endothelial cells [60]. It plays an important role in the formation of several types of storage granules, especially in mast cells [61].

Yin W, Cheepala S, Roberts JN, Syson-Chan K, DiGiovanni J, Clifford JL: Active Stat3 buy Inhibitor Library is required for survival of human squamous cell carcinoma cells in serum-free conditions. Mol Cancer 2006, 5:15.PubMedCrossRef 14. Kataoka K, Kim DJ, Carbajal S, Clifford J, DiGiovanni J: Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis. Carcinogenesis 2008,

29:1108–1114.PubMedCrossRef 15. Syed Z, Cheepala SB, Gill JN, Stein J, Nathan CA, Digiovanni J, Batra V, Adegboyega P, Kleiner HE, Clifford JL: All-trans retinoic acid suppresses Stat3 signaling during skin carcinogenesis. Cancer Prev Res (Phila Pa) 2009, 2:903–911.CrossRef 16. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE Jr: Stat3 as an oncogene. Cell 1999, 98:295–303.PubMedCrossRef 17. Chan KS, Sano S, Kataoka K, Abel E, Carbajal S, Beltran L, Clifford J, Peavey M, Shen J, Digiovanni J: Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis. Oncogene 2008, 27:1087–1094.PubMedCrossRef 18. Karin M: Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431–436.PubMedCrossRef 19. Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB: Inhibition of growth and survival of human head

and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int J Cancer 2004, 111:679–692.PubMedCrossRef 20. Loercher MK 8931 concentration A, Lee TL, Ricker JL, Howard A, Geoghegen J, Chen Z, Sunwoo JB, Sitcheran R, Chuang EY, Mitchell JB, Baldwin AS Jr, Van

Waes C: Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer Res 2004, 64:6511–6523.PubMedCrossRef 21. Kobielak A, Fuchs E: Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin. Proc Natl Acad Sci USA 2006, 103:2322–2327.PubMedCrossRef 22. Mukhtar H, Agarwal R: Skin cancer chemoprevention. J Investig Dermatol Symp Proc 1996, 1:209–214.PubMed 23. Gupta S, Mukhtar H: Chemoprevention of skin cancer: current status and future prospects. Cancer Metastasis Rev 2002, 21:363–380.PubMedCrossRef 24. Bickers DR, Athar M: Novel approaches to chemoprevention of skin cancer. J Dermatol 2000, 27:691–695.PubMed 25. L-gulonolactone oxidase Kondo A, Ohigashi H, Murakami A, Suratwadee J, Koshimizu K: 1′-Acetoxychavicol Acetate as a Potent inhibitor of Tumor Promoter-induced Epstein-Barre Virus Activation from Languas galanga, a Traditional Thai Condiment. Biosci. Biotech. Biochem 1993, 57:1344–1345.CrossRef 26. Murakami A, Kuki W, Takahashi Y, Yonei H, Nakamura Y, Ohto Y, Ohigashi H, Koshimizu K: Auraptene, a citrus coumarin, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in ICR mouse skin, possibly through suppression of superoxide generation in leukocytes. Jpn J Cancer Res 1997, 88:443–452.

References 1. Murphy TF: Respiratory infections caused by non-typeable Haemophilus influenzae. Curr Opin Infect Dis 2003,16(2):129–134.PubMedCrossRef 2. Murphy TF, Brauer AL, Schiffmacher AT, Sethi S: Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170:266–272.PubMedCrossRef 3. Hoberman A, Marchant CD, Kaplan SL, Feldman S: Treatment of acute otitis media consensus recommendations. Clin Pediatr (Phila) 2002,41(6):373–390.CrossRef

4. Pelton SI: Acute otitis media in an era of increasing antimicrobial resistance and universal administration of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2002,21(6):599–604. discussion 613–594PubMedCrossRef Alisertib clinical trial Selleck SB273005 5. Hong W, Mason K, Jurcisek J, Novotny L, Bakaletz LO,

Swords WE: Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86–028NP in a chinchilla model of otitis media. Infect Immun 2007,75(2):958–965.PubMedCrossRef 6. Slinger R, Chan F, Ferris W, Yeung SW, St Denis M, Gaboury I, Aaron SD: Multiple combination antibiotic susceptibility testing of nontypeable Haemophilus influenzae biofilms. Diagn Microbiol Infect Dis 2006,56(3):247–253.PubMedCrossRef 7. Forsgren J, Samuelson A, Ahlin A, Jonasson J, Rynnel-Dagoo B, Lindberg A: Haemophilus influenzae resides and multiplies intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay. Infect Immun 1994,62(2):673–679.PubMed 8. Swords WE, Buscher BA, Ver Steeg IK, Preston A, Nichols WA, Weiser JN, Gibson BW, Apicella MA: Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol Microbiol 2000,37(1):13–27.PubMedCrossRef 9. Bandi V, Apicella MA, Mason E, Murphy TF,

Siddiqi A, Atmar RL, Greenberg SB: Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med 2001,164(11):2114–2119.PubMed 10. Ketterer Urease MR, Shao JQ, Hornick DB, Buscher B, Bandi VK, Apicella MA: Infection of primary human bronchial epithelial cells by Haemophilus influenzae: macropinocytosis as a mechanism of airway epithelial cell entry. Infect Immun 1999, 67:4161–4170.PubMed 11. Ehrlich GD, Veeh R, Wang X, Costerton JW, Hayes JD, Hu FZ, Daigle BJ, Ehrlich MD, Post JC: Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA 2002,287(13):1710–1715.PubMedCrossRef 12. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, Forbes M, Greenberg DP, Dice B, Burrows A, et al.: Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006,296(2):202–211.PubMedCrossRef 13.

Tumor necrosis factor-alpha-induced iron sequestration and oxidative stress in human endothelial cells. Arterioscler Thromb Vasc Biol. 2005;25:2495–501.PubMedCrossRef 41. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA. 2001;98:8780–5.PubMedCrossRef 42. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O. A new mouse liver-specific gene, encoding a protein LY2603618 in vitro homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem.

2001;276:7811–9.PubMedCrossRef 43. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090–3.PubMedCrossRef 44. Brasse-Lagnel C, Karim Z, Letteron P, Bekri S, Bado A, Beaumont C. Intestinal DMT1 cotransporter is downregulated by hepcidin via proteasome-internalization and degradation. Gastroenterology. 2011;140:1261–71.PubMedCrossRef 45. Kuragano T, Shimonaka Y, Kida A, Furuta M, Nanami M, Otaki Y, Hasuike Y, Nonoguchi H, Nakanishi T. Determinants of hepcidin

in patients on maintenance hemodialysis: role of inflammation. Am J Nephrol. 2010;31:534–40.PubMedCrossRef 46. Weiss G, Theurl I, Eder AZD0156 cell line S, Koppelstaetter C, Kurz K, Sonnweber T, Kobold U, Mayer G. Serum hepcidin concentration Leukotriene-A4 hydrolase in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy. Eur J Clin Invest. 2009;39:883–90.PubMedCrossRef 47. Ford BA, Eby CS, Scott MG, Coyne DW. Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients. Kidney Int. 2010;78:769–73.PubMedCrossRef 48. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271–6.PubMed

49. Nakanishi T, Kuragano T, Nanami M, Otaki Y, Nonoguchi H, Hasuike Y. Importance of ferritin for optimizing anemia therapy in chronic kidney disease. Am J Nephrol. 2010;32:439–46.PubMedCrossRef 50. Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, Eberwein L, Witcher DR, Murphy AT, Wroblewski VJ, Wurz E, Datz C, Weiss G. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood. 2009;113:5277–86.PubMedCrossRef 51. Theurl I, Finkenstedt A, Schroll A, Nairz M, Sonnweber T, Bellmann-Weiler R, Theurl M, Seifert M, Wroblewski VJ, Murphy AT, Witcher D, Zoller H, Weiss G. Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia. Br J Haematol. 2010;148:449–55.PubMedCrossRef 52.